the weave logo animated in a loading state

About Weave

Weave Bio is the company behind the Weave Platform, an AI-native solution built to support regulatory workflows across the therapy lifecycle. Designed for pharmaceutical companies, biotech firms, CROs, and regulatory consultants, the platform helps teams prepare and manage complex dossiers more efficiently by combining AI-powered authoring, content reuse, and streamlined responses to health authority questions.

With Weave, regulatory teams gain greater speed, consistency, and confidence in their work through an AI-driven, human-powered approach that enhances regulatory quality while reducing time and effort.

Our Leadership

A perfect mix of life science, AI, regulatory, and software experience.

Brandon Rice

Chief Executive Officer

Ari Caroline

Chief Strategy Officer

Umut Eser

Chief AI Officer

Sean Campbell

Chief Operating Officer

Lindsay Mateo

Chief Commercial Officer

Levi Malott

Chief Technology Officer

Our Investors

We partner with industry-leading experts to bring the very best technology and insights to the company

How we got here

December 2023

Seed funding from Innovation Endeavors and Magnetic Ventures

January 2024

Company launch with a focus on platform development

March 2024

Early release of AutoIND, our AI-native solution for IND preparation

June 2024

Full commercial launch of AutoIND for pharma and biotech customers

November 2024

Weave Bio Earns the 2024 “BioTech AI Innovation Of The Year” Award

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.